Tianzhou Ma

Dr. Tianzhou Ma

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2021 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
OAOluwasanmi O Adenaiye
Oluwasanmi O Adenaiye
JLJianyu Lai
Jianyu Lai
PMP Jacob Bueno de Mesquita
P Jacob Bueno de Mesquita
FHFilbert Hong
Filbert Hong
SYSomayeh Youssefi
Somayeh Youssefi
DMDonald K Milton
Donald K Milton
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemiology implicates airborne transmission; aerosol infectiousness and impacts of masks and variants on aerosol shedding are not well understood. Methods: We recruited coronavirus disease 2019 (COVID-19) cases to give blood, saliva, mid-turbinate and fomite (phone) swabs, and 30-minute breath samples while vocalizing into a Gesundheit-II, with and without masks at up to 2 visits 2 days apart. We quantified and sequenced viral RNA, cultured virus, and assayed serum samples for anti-spike and anti-receptor binding domain antibodies. Results: We enrolled 49 seronegative cases (mean days post onset 3.8 ± 2.1), May 2020 through April 2021. We detected SARS-CoV-2 RNA in 36% of fine (≤5 µm), 26% of coarse (>5 µm) aerosols, and 52% of fomite samples overall and in all samples from 4 alpha variant cases. Masks reduced viral RNA by 48% (95% confidence interval [CI], 3 to 72%) in fine and by 77% (95% CI, 51 to 89%) in coarse aerosols; cloth and surgical masks were not significantly different. The alpha variant was associated with a 43-fold (95% CI, 6.6- to 280-fold) increase in fine aerosol viral RNA, compared with earlier viruses, that remained a significant 18-fold (95% CI, 3.4- to 92-fold) increase adjusting for viral RNA in saliva, swabs, and other potential confounders. Two fine aerosol samples, collected while participants wore masks, were culture-positive. Conclusions: SARS-CoV-2 is evolving toward more efficient aerosol generation and loose-fitting masks provide significant but only modest source control. Therefore, until vaccination rates are very high, continued layered controls and tight-fitting masks and respirators will be necessary.

10 October 2018 in Bioinformatics
Verified
Journal Article
Closed access
TMTianzhou Ma
Tianzhou Ma
ZHZhiguang Huo
Zhiguang Huo
AKAnche Kuo
Anche Kuo
LZLi Zhu
Li Zhu
ZFZhou Fang
Zhou Fang
George C. TsengGeorge C. Tseng
George C. Tseng
Summary: The rapid advances of omics technologies have generated abundant genomic data in public repositories and effective analytical approaches are critical to fully decipher biological knowledge inside these data. Meta-analysis combines multiple studies of a related hypothesis to improve statistical power, accuracy and reproducibility beyond individual study analysis. To date, many transcriptomic meta-analysis methods have been developed, yet few thoughtful guidelines exist. Here, we introduce a comprehensive analytical pipeline and browser-based software suite, called MetaOmics, to meta-analyze multiple transcriptomic studies for various biological purposes, including quality control, differential expression analysis, pathway enrichment analysis, differential co-expression network analysis, prediction, clustering and dimension reduction. The pipeline includes many public as well as >10 in-house transcriptomic meta-analytic methods with data-driven and biological-aim-driven strategies, hands-on protocols, an intuitive user interface and step-by-step instructions. Availability and implementation: MetaOmics is freely available at https://github.com/metaOmics/metaOmics. Supplementary information: Supplementary data are available at Bioinformatics online.

5 September 2023 in Journal Of Hypertension
Verified
Journal Article
Closed access
LFLi Feng
Li Feng
ZYZhenyao Ye
Zhenyao Ye
CMChen Mo
Chen Mo
JWJingtao Wang
Jingtao Wang
SLSong Liu
Song Liu
TMTianzhou Ma
Tianzhou Ma
Background: Elevated blood pressure (BP) is a modifiable risk factor associated with cognitive impairment and cerebrovascular diseases. However, the causal effect of BP on white matter brain aging remains unclear. Methods: In this study, we focused on N = 228 473 individuals of European ancestry who had genotype data and clinical BP measurements available (103 929 men and 124 544 women, mean age = 56.49, including 16 901 participants with neuroimaging data available) collected from UK Biobank (UKB). We first established a machine learning model to compute the outcome variable brain age gap (BAG) based on white matter microstructure integrity measured by fractional anisotropy derived from diffusion tensor imaging data. We then performed a two-sample Mendelian randomization analysis to estimate the causal effect of BP on white matter BAG in the whole population and subgroups stratified by sex and age brackets using two nonoverlapping data sets. Results: The hypertension group is on average 0.31 years (95% CI = 0.13–0.49; P < 0.0001) older in white matter brain age than the nonhypertension group. Women are on average 0.81 years (95% CI = 0.68–0.95; P < 0.0001) younger in white matter brain age than men. The Mendelian randomization analyses showed an overall significant positive causal effect of DBP on white matter BAG (0.37 years/10 mmHg, 95% CI 0.034–0.71, P = 0.0311). In stratified analysis, the causal effect was found most prominent among women aged 50–59 and aged 60–69. Conclusion: High BP can accelerate white matter brain aging among late middle-aged women, providing insights on planning effective control of BP for women in this age group.

28 October 2024 in Nicotine & Tobacco Research
Verified
Journal Article
Closed access
PDF file
YPYezhi Pan
Yezhi Pan
CBChuan Bi
Chuan Bi
ZYZhenyao Ye
Zhenyao Ye
HLHwiyoung Lee
Hwiyoung Lee
JYJiaao Yu
Jiaao Yu
SCShuo Chen
Shuo Chen
Introduction: Nicotine addiction, a multifaceted neuropsychiatric disorder, profoundly impacts brain functions through interactions with neural pathways. Despite its significance, the impact of tobacco smoking on the whole-brain functional connectome remains largely unexplored. Aims and Methods: We conducted a whole-brain analysis on 24 539 adults aged 40 and above from the United Kingdom Biobank cohort. Subjects were categorized into individuals who use nicotine and those who do not use nicotine based on current and chronic tobacco smoking information. Functional connectivity was assessed using resting-state functional magnetic resonance imaging. We employed a network analysis method to assess the systematic effects of tobacco smoking on brain connectome by identifying subnetworks that show nicotine-use-related differences. Results: Our analyses revealed two nicotine-use-related subnetworks with distinct network structure (permutation p < .001). In the first network, there is a significant decrease in resting-state functional connectivity (rsFC) between the basal ganglia regions (eg, nucleus accumbens) and 73% of the remaining brain regions, emphasizing the central hub role of basal ganglia in addictive smoking behaviors. Additionally, a data-driven subnetwork, mainly involving regions from frontal and occipital lobes, showed reduced rsFC among individuals who use nicotine. Conclusions: The results suggest significant alterations in the communication and coordination among the basal ganglia and the broader network of brain regions. The observed changes in rsFC indicate a widespread disruption in the connectivity patterns associated with nicotine use. Implications: This study identifies rsFC subnetworks related to chronic nicotine use through whole-brain connectome analysis. The findings confirm that widespread alterations in rsFC are centered around hub nodes within the basal ganglia, including bilateral nucleus accumbens, putamen, caudate, and globus pallidus. In addition, our analysis found a clique-forming subnetwork vulnerable to tobacco smoking consisting of regions from the visual, dorsal/ventral attention, and frontoparietal networks.

20 July 2022 in Bioinformatics
Verified
Journal Article
Closed access
PDF file
HKHongjie Ke
Hongjie Ke
ZRZhao Ren
Zhao Ren
JQJianfei Qi
Jianfei Qi
SCShuo Chen
Shuo Chen
George C. TsengGeorge C. Tseng
George C. Tseng
TMTianzhou Ma
Tianzhou Ma
The advancement of high-throughput technology characterizes a wide variety of epigenetic modifications and noncoding RNAs across the genome involved in disease pathogenesis via regulating gene expression. The high dimensionality of both epigenetic/noncoding RNA and gene expression data make it challenging to identify the important regulators of genes. Conducting univariate test for each possible regulator–gene pair is subject to serious multiple comparison burden, and direct application of regularization methods to select regulator–gene pairs is computationally infeasible. Applying fast screening to reduce dimension first before regularization is more efficient and stable than applying regularization methods alone. We propose a novel screening method based on robust partial correlation to detect epigenetic and noncoding RNA regulators of gene expression over the whole genome, a problem that includes both high-dimensional predictors and high-dimensional responses. Compared to existing screening methods, our method is conceptually innovative that it reduces the dimension of both predictor and response, and screens at both node (regulators or genes) and edge (regulator–gene pairs) levels. We develop data-driven procedures to determine the conditional sets and the optimal screening threshold, and implement a fast iterative algorithm. Simulations and applications to long noncoding RNA and microRNA regulation in Kidney cancer and DNA methylation regulation in Glioblastoma Multiforme illustrate the validity and advantage of our method. The R package, related source codes and real datasets used in this article are provided at https://github.com/kehongjie/rPCor. Supplementary data are available at Bioinformatics online.

2 February 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
WZWei Zong
Wei Zong
TRTanbin Rahman
Tanbin Rahman
LZLi Zhu
Li Zhu
XZXiangrui Zeng
Xiangrui Zeng
YZYingjin Zhang
Yingjin Zhang
George C. TsengGeorge C. Tseng
George C. Tseng
Model organisms are instrumental substitutes for human studies to expedite basic, translational, and clinical research. Despite their indispensable role in mechanistic investigation and drug development, molecular congruence of animal models to humans has long been questioned and debated. Little effort has been made for an objective quantification and mechanistic exploration of a model organism’s resemblance to humans in terms of molecular response under disease or drug treatment. We hereby propose a framework, namely Congruence Analysis for Model Organisms (CAMO), for transcriptomic response analysis by developing threshold-free differential expression analysis, quantitative concordance/discordance scores incorporating data variabilities, pathway-centric downstream investigation, knowledge retrieval by text mining, and topological gene module detection for hypothesis generation. Instead of a genome-wide vague and dichotomous answer of “poorly” or “greatly” mimicking humans, CAMO assists researchers to numerically quantify congruence, to dissect true cross-species differences from unwanted biological or cohort variabilities, and to visually identify molecular mechanisms and pathway subnetworks that are best or least mimicked by model organisms, which altogether provides foundations for hypothesis generation and subsequent translational decisions.